Healthcare -
Drug Manufacturers - General - NYSE - US
$ 171.56
-1.23 %
$ 303 B
Market Cap
59.99
P/E
Price Target
Average
16.89%
Revenue Forecast
Estimate
9.68%
EBIT
Estimate
22.95%
Net Income
Estimate
82.31%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AbbVie Inc.
Wall Street analysts predict an average 1-year price target for ABBV of $201 , with forecasts ranging from
a
low of
$175 to a high of $228 .
ABBV Lowest Price Target
Wall Street Target
175 USD
2.01%
ABBV Average Price Target
Wall Street Target
201 USD
16.89%
ABBV Highest Price Target
Wall Street Target
228 USD
32.90%
REVENUE FORECAST
Revenue Forecast Chart ABBV
EBIT FORECAST
EBIT Forecast Chart ABBV
NET INCOME FORECAST
Net Income Chart ABBV